# Phase II Study of Modified Triple Doublet Therapy in Women With Newly Diagnosed Mullerian Carcinoma

> **NCT00157560** · PHASE2 · COMPLETED · sponsor: **Massachusetts General Hospital** · enrollment: 83 (—)

## Conditions studied

- Ovarian Cancer
- Fallopian Tube Cancer
- Primary Peritoneal Cancer

## Interventions

- **DRUG:** Chemotherapy, multiple agents

## Key facts

- **NCT ID:** NCT00157560
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-12
- **Primary completion:** 2006-11
- **Final completion:** 2005-07
- **Target enrollment:** 83 (—)
- **Last updated:** 2008-01-03

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00157560

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00157560, "Phase II Study of Modified Triple Doublet Therapy in Women With Newly Diagnosed Mullerian Carcinoma". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00157560. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*